Cite
HARVARD Citation
Gao, F. et al. (2022). Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation. American journal of hematology. 97 (2), pp. E44-E47. [Online].